Jul 9, 2026 07:27AM
Jun 25, 2026 07:27AM
Jun 23, 2026 07:27AM
May 14, 2026 07:27AM
May 7, 2026 07:27AM
Apr 28, 2026 07:27AM
Apr 28, 2026 07:27AM Cardiol Therapeutics Expands U.S. MAVERIC Phase III Trial Network to Address Growing Interest in the Pivotal Program
Apr 14, 2026 07:29AM
Apr 14, 2026 07:27AM
Apr 1, 2026 07:33AM
Apr 1, 2026 07:27AM
Feb 25, 2026 07:27AM
Feb 10, 2026 07:29AM
Feb 10, 2026 07:27AM Cardiol Therapeutics' ARCHER Phase II Study Results Published in ESC Heart Failure
Jan 23, 2026 09:16AM
Jan 16, 2026 08:48AM
Jan 16, 2026 08:46AM
Jan 16, 2026 08:43AM
Jan 16, 2026 08:42AM
Jan 13, 2026 07:29AM
Jan 13, 2026 07:27AM Cardiol Therapeutics Achieves Key 50% Patient Enrollment Milestone in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis
Dec 2, 2025 06:43AM
Dec 1, 2025 07:29AM
Dec 1, 2025 07:27AM
Nov 13, 2025 07:48AM
Nov 13, 2025 07:45AM
Nov 5, 2025 07:45AM
Oct 21, 2025 07:27AM Cardiol Therapeutics Completes US$11.4 Million Financing and Extends Cash Runway into Q3 2027
Oct 17, 2025 04:36PM
Oct 17, 2025 04:34PM
Aug 11, 2025 07:27AM
Aug 6, 2025 07:27AM
Jul 22, 2025 07:30AM
Jul 22, 2025 07:27AM
May 29, 2025 07:27AM Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders
May 27, 2025 07:27AM
Apr 29, 2025 07:29AM
Apr 29, 2025 07:27AM
Apr 16, 2025 07:29AM
Apr 16, 2025 07:27AM
Apr 8, 2025 06:45AM
Apr 1, 2025 07:29AM Cardiol Therapeutics (CRDL) Issues Year-end Update on Operations
Apr 1, 2025 07:27AM
Mar 3, 2025 07:27AM
Feb 20, 2025 07:29AM
Feb 20, 2025 07:27AM
Feb 4, 2025 07:27AM
Dec 19, 2024 08:30AM
Nov 18, 2024 11:37AM Cardiol Therapeutics' Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024
Nov 13, 2024 08:00AM

325,451 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All